Nuvation Bio Completes Acquisition of AnHeart Therapeutics :

10.04.2024 - Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of the acquisition of ... Seite 1

Related Keywords

Nuvation Bio , Junyuan Jerry Wang , , David Hung , Chief Executive , Min Cui , Managing Director , Decheng Capital , Chief Executive Officer , Non Voting Convertible Preferred Stock , Nuvation Bio Chart , Uvation Bio Kurs , Uvation Bio Aktie ,